Health Care/Hospital
RedHill Biopharma Announces Planned Expansion of Opaganib Global Phase 2/3 COVID-19 Study to the U.S.
TEL AVIV, Israel and RALEIGH, NC, Feb. 23, 2021 /PRNewswire/ -- RedHill
Biopharma Ltd.
2021-02-23 20:33
3705
Barco Applauded by Frost & Sullivan for its Continued Domination of the Wireless Content Sharing Market
Its successful ClickShare product line, wide footprint, and strong technology partnership have helped it maintain its competitive edge SANTA CLARA, Calif., Feb. 23, 2021 /PRNewswire/ -- Based on its recent analysis of the global stand-alone wireless content sharing market,Frost & Sullivan recogn...
2021-02-23 20:17
1180
For third year straight, Elekta named one of the world's most ethical companies by Ethisphere
STOCKHOLM, Feb. 23, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has again been recognized as one of theWorld's Most Ethical Companies® by the Ethisphere Institute, a global leader in defining and advancing the standards of ethical business practices. The honor is bestowed upo...
2021-02-23 20:02
3151
Kira Pharmaceuticals Expands Executive Leadership Team with Chief Business Officer, Chief Medical Officer and Chief Commercial Officer, China
CAMBRIDGE, Mass. and SUZHOU, China, Feb. 23, 2021 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases, today announced the addition of three seasoned pharmaceutical leaders,Kathy He, R...
2021-02-23 20:00
2670
New Progress in Study on Mechanism of Lianhua Qingwen Capsules for Treatment of COVID-19
SHIJIAZHUANG, China, Feb. 23, 2021 /PRNewswire/ -- Recently, Prof. Caisheng Wu and Prof.Yifeng Chai from the School of Pharmacy, Xiamen University have made new progress in the study of the pharmacologically active ingredients and mechanism of Lianhua Qingwen Capsules, developed and produced by Y...
2021-02-23 17:05
2058
Molecular Stethoscope Announces Publication of its NAFLD/NASH Study in the American Journal of Physiology - Gastrointestinal and Liver Physiology
Circulating cell-free mRNA in blood reflective of NAFLD/NASH liver pathology PALO ALTO, Calif., Feb. 23, 2021 /PRNewswire/ -- Molecular Stethoscope, Inc., a precision medicine biotechnology company, announces publication of its human proof-of-concept study describing the stratification of NAFLD/N...
2021-02-23 16:00
1258
Clover Biopharmaceuticals Raises $230 Million in Oversubscribed Series C Financing
* Series C financing brings total capital raised in the last 12 months to over US$ 400 million (>RMB 2.5 billion) * The proceeds will support the continued development and expansion of Clover's pipeline of protein-based vaccines and biologic cancer therapies CHENGDU, China, Feb. 23, 2021 /PRNe...
2021-02-23 10:59
2323
The BCMA CAR-T Co-developed by Innovent and IASO Was Granted Breakthrough Therapy Designation by the NMPA for the Treatment of Relapsed/Refractory Multiple Myeloma
SAN FRANCISCO and SUZHOU, China, Feb. 23, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
2021-02-23 09:22
5113
AnchorDx Completes USD 40 Million Series C Financing to Advance Cancer Screening and Early Detection Programs
GUANGZHOU, China, Feb. 23, 2021 /PRNewswire/ -- AnchorDx Medical Co., Ltd. ("AnchorDx") announced the completion of aUSD 40 million Series C financing. This round of financing was jointly led by OrbiMed, a world-renowned biomedicine and healthcare venture capital fund, and WuXi Huiying Investment...
2021-02-23 09:02
2245
Surgical Wait Times Technology Now Available in Australia and New Zealand
Fastest Growing Canadian Health Technology Company Expands Into ANZ SYDNEY, Feb. 23, 2021 /PRNewswire/ -- Wait times in both Australia and New Zealand are too long and how patients are admitted for surgery hasn't changed in decades. Unlike elsewhere, the process is unnecessarily antiquated and ...
2021-02-23 05:00
854
SecurityHQ Release New Mobile App
LONDON, Feb. 23, 2021 /PRNewswire/ -- SecurityHQ, the leading provider in
managed security services, launch their new Mobile App, SecurityHQ Response.
2021-02-23 03:00
2490
Octapharma AG: Final data from the NuProtect study published on the immunogenicity of Nuwiq® in previously untreated patients with severe haemophilia A
LACHEN, Switzerland, Feb. 23, 2021 /PRNewswire/ -- Octapharma announced today that the final results from the NuProtect study on the immunogenicity of Nuwiq® in previously untreated patients (PUPs) with severe haemophilia A have been published in the leading medical journalThrombosis and Haemosta...
2021-02-23 00:51
2557
Frost & Sullivan Reveals Regional Trends and Cutting-edge Technologies in the Global MRI Market
Advanced technologies and applications such as point-of-care, pediatrics, dry-magnets, compact MRI and fusion imaging are driving global market SANTA CLARA, Calif., Feb. 23, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis,Technological Advancements and Emerging Applications in the Global ...
2021-02-23 00:48
1142
Dr. Ren Feng Appointed as Chief Scientific Officer of Insilico Medicine
Pharmaceutical veteran joins Insilico Medicine to apply Artificial Intelligence to build a portfolio of Insilico Medicine's proprietary assets and further pipeline development HONG KONG, Feb. 22, 2021 /PRNewswire/ -- Insilico Medicine (the "Company"), a global leader in artificial intelligence f...
2021-02-22 23:28
1634
Los Angeles Lakers Name Hyperice Official Recovery Technology Sponsor
First NBA Team Deal Returns the Recovery Technology Leader to its Southern California Roots EL SEGUNDO, Calif. and IRVINE, Calif., Feb. 22, 2021 /PRNewswire/ -- The Los Angeles Lakers andHyperice announced today a multi-season sponsorship agreement that names Hyperice the Official Recovery Techn...
2021-02-22 22:00
2720
Curocell announces Korean FDA clearance of the IND for CRC01, a first in kind immune checkpoint receptors downregulated CD19 CAR-T therapy
DAEJEON, South Korea, Feb. 22, 2021 /PRNewswire/ -- Curocell, Inc., a clinical-stage biotech developing next-generation CAR-T (OVIS™) therapies, announced that the Ministry of Food and Drug Safety (MFDS) of Korea has approved its Phase 1/2 clinical study application forCRC01, CD19 CAR-T cell the...
2021-02-22 22:00
1188
BioVaxys Announces Appointment To Its Scientific Advisory Board
VANCOUVER, B.C., Feb. 22, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys"), a biotechnology company that is advancing viral and oncology vaccine platforms as well as immuno-diagnostic products, today announced the appointment of Kartik Chandran Ph.D....
2021-02-22 21:00
1881
ABclonal Biotechnology Completes $93 Million Series C Financing
WOBURN, Mass., Feb. 22, 2021 /PRNewswire/ -- ABclonal Biotechnology, a global life science tools and services provider, recently completed its$92.9 million Series C financing led by Sequoia Capital China and healthcare-focused investor LYFE Capital. Other new and existing shareholders, such as Si...
2021-02-22 20:00
1548
Positive BNC210 7-Day Dosing Pharmacokinetic Study Exceeds Blood Exposure Projected for Phase 2b PTSD Trial
* BNC210 novel oral tablet formulation (900 mg given twice daily) exceeds blood exposure projected for upcoming Phase2b PTSD trial * BNC210 Phase 2b PTSD trial on target for start in mid-2021 with final dose selected ADELAIDE, Australia, Feb. 22, 2021 /PRNewswire/ -- Bionomics Limited (ASX: B...
2021-02-22 19:00
3011
Completion of Patients' Recruitment for Proxalutamide's COVID-19 Hospitalised Study
SUZHOU, China, Feb.22, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX:9939) is pleased to announce that the clinical trial of Proxalutamide for the treatment of hospitalised COVID-19 patients inBrazil completed the recruitment of 588 patients. The data of the clinical trial is expected ...
2021-02-22 17:14
2996
Week's Top Stories
Most Reposted
Multiple achievements made in China-Hungary BRI conference
[Picked up by 319 media titles]
2024-05-03 06:59
Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity
[Picked up by 317 media titles]
2024-05-07 08:00
Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 289 media titles]
2024-05-03 06:25TAILG Makes Grand Appearance at 2024 Asiabike Jakarta, Aiming to Set the Benchmark in Indonesia
[Picked up by 262 media titles]
2024-05-02 01:21
China-Serbia forum highlights community with shared future for mankind
[Picked up by 245 media titles]
2024-05-01 11:39
Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
14378
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
9999
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
9532
